Vilazodone and Abciximab: Interaction Details

Brand names
Vilazodone
Viibryd
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Abciximab

We don't have a drug information page for Abciximab because it is no longer sold in the US: the FDA lists every licensed version as discontinued. Have a question about Abciximab? Ask a pharmacist, free →

What Happens When You Take Vilazodone With Abciximab

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Vilazodone should be coadministered with or drugs only with caution, because taking them together may raise the likelihood of bleeding.312 The mechanism may involve vilazodone's influence on release from . Patients should be told that using vilazodone together with antiplatelet drugs or anticoagulants carries a higher risk of bleeding.1

The Vilazodone and Abciximab Interaction, Explained

Vilazodone (Viibryd) is an antidepressant that affects . , the blood cells that help clots form, use serotonin to work well. Abciximab is a strong medicine that stops platelets from clumping, and it is usually given in a hospital during heart procedures. Together, they may make you bleed more easily, for example with nosebleeds, easy bruising, or bleeding gums.

This risk is mainly theoretical, meaning it is based on how the drugs work rather than on large studies. Your care team can manage it by watching you closely. Tell them you take vilazodone, and report any unusual bleeding or bruising right away. Do not stop either medicine on your own.

Mechanism: Vilazodone, an and 5-HT1A partial , inhibits reuptake and may deplete serotonin, which impairs platelet aggregation. Abciximab (a GP IIb/IIIa ) blocks the final common pathway of platelet aggregation. The effects on hemostasis are , so bleeding risk increases ( interaction, not a -mediated one).

  • Evidence: theoretical; onset unspecified; severity rated major.
  • Management: use caution with . Monitor for signs of bleeding (mucosal, , access-site, hematuria) and hemoglobin/hematocrit as clinically indicated. Counsel patients on the increased bleeding risk.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Vilazodone and Abciximab Interact

The likely mechanism

Release of by ; effects on hemostasis

In short: Vilazodone and abciximab both make bleeding more likely, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Vilazodone and Abciximab Interaction

Your care team can usually manage this by using the combination carefully and watching for bleeding. Abciximab is typically given in a monitored hospital setting, so your team will already be checking on you.

  • Keep taking vilazodone as prescribed unless your doctor tells you otherwise.
  • Tell every prescriber and pharmacist that you take vilazodone, especially before procedures.
  • Report unusual bruising, nosebleeds, bleeding gums, black or bloody stools, or blood in urine.
  • Ask your care team what bleeding signs to watch for.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Vilazodone or Abciximab need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction

    A retrospective study enrolled patients older than 50 years with a diagnosis of acute myocardial infarction (N=27,058). In this cohort, taking an together with any therapy significantly raised the bleeding risk 1.42-fold relative to aspirin alone. Treatment with aspirin, clopidogrel, and an SSRI significantly raised the risk 2.35-fold relative to aspirin alone and 1.57-fold relative to the combination of clopidogrel and aspirin.2

  2. Report 2 · Study title

    Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis

    A systematic review and meta-analysis of 22 observational studies found that use was associated with a significant 1.55-fold higher risk of upper bleeding (UGIB). When were used together with drugs, the risk of UGIB was 2.48 times higher (3 studies).3

  3. Report 3 · Study title

    Prescribing information: VIIBRYD oral tablets, vilazodone HCl oral tablets

    Case-control and cohort studies have linked the combined use of and norepinephrine reuptake (such as vilazodone) with agents to a higher risk of bleeding. Data from published observational studies indicate that exposure, especially during the month before delivery, has been associated with an increase of less than 2-fold in the risk of postpartum . The reported bleeding events have included epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages.1

Vilazodone and Abciximab: Common Questions

How serious is the Vilazodone and Abciximab interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Vilazodone and Abciximab interaction managed?

Your care team can usually manage this by using the combination carefully and watching for bleeding. Abciximab is typically given in a monitored hospital setting, so your team will already be checking on you. Keep taking vilazodone as prescribed unless your doctor tells you otherwise. Tell every prescriber and pharmacist that you take vilazodone, especially before procedures. Report unusual bruisi… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Vilazodone and Abciximab Interaction

Ask in your own words about taking Vilazodone and Abciximab together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: VIIBRYD(R) oral tablets, vilazodone HCl oral tablets. Allergan USA Inc (per FDA), Madison, NJ, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?

Other Serious Interactions of Vilazodone and Abciximab

Also serious with Vilazodone

Also serious with Abciximab

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Vilazodone

With Abciximab

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.